Cross-protective effect of a multicomponent fusion protein vaccine during a natural episode of Streptococcus zooepidemicus respiratory disease in ponies.
Аннотация
BACKGROUND
Streptococcus equi subspecies zooepidemicus is a highly diverse opportunistic pathogen of horses, associated with respiratory disease and endometritis.
OBJECTIVES
To characterise S. zooepidemicus isolates recovered from young ponies during a natural episode of respiratory disease, and to determine if vaccination with Strangvac®, a vaccine against Streptococcus equi subspecies equi, conferred cross-protection.
STUDY
DESIGN
Retrospective analysis of a double-blinded placebo-controlled study involving 32 ponies (16 vaccinates and 16 placebo controls) that experienced a natural episode of respiratory disease around the time of second vaccination.
METHODS
Ponies were monitored daily for clinical signs of respiratory infection. Nasopharyngeal swabs were taken from affected animals to identify equine pathogens by qPCR and culture. The genomes of 23 S. zooepidemicus isolates were sequenced. Clinical and serological differences between vaccine and placebo groups were determined.
RESULTS
The clinical samples were positive for equine herpes virus-4 or S. zooepidemicus (1/15 [7%] and 13/15 [87%], respectively). Seven different S. zooepidemicus sequence types, which encoded between four and seven of the eight antigens in Strangvac® with ≥70% amino acid identity, were recovered from affected horses. The most conserved antigens were CNE, EAG, Eq5 and IdeE. The number of days that ponies had a cough was significantly associated (p = 0.005) with the vaccination status, with fewer days in the vaccinated compared to co-mingled control ponies (1.8 ± 1.9 days vs. 3.4 ± 3.5 days). A higher antibody titre to IdeE immediately prior to second vaccination correlated with a lower cumulative coughing score (p = 0.03). A reduced number of days with abnormal temperature correlated with increased antibody levels against Eq85 (p = 0.023-0.028).
MAIN LIMITATIONS: Small group size.
CONCLUSIONS
This study provides evidence in support of a cross-protective effect of Strangvac® for the reduction of clinical signs associated with natural infection with S. zooepidemicus, which correlated with the presence of higher antibody titres to IdeE and Eq85.
Подготовка и перевод публикации
Обработка статьи · этапы, ошибки и управление
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Тип публикации указан по данным источника. Уровень доказательности автоматически не присваивается.